Brian Frezza

Emerald Therapeutics

Brian M. Frezza is Co-founder and Co-CEO of Emerald Therapeutics, where he spearheads Emerald’s therapeutic research effort and is lead architect of the the Emerald Cloud Lab (ECL), a remote controlled life science laboratory. Brian completed his PhD in Chemical Biology at The Scripps Research Institute (TSRI) working on DNA nanotechnology under committee mentorship of Feynman award-winning chemists M. Reza Ghadiri and Nadrian Seeman. Brian is a Hollerith and Wolfram Innovator award-winner who has received over a hundred combined citations for published articles in the Journal of the American Chemical Society (JACS) and Chemical Physics. He has also served as a peer reviewer for both JACS and Langmuir, and guest-lectured at Carnegie Mellon University, TSRI, and Stanford University.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search